US FDA’s Pazdur Wants Clinicians To Help Set Oncology Research Agenda

 
• By Derrick Gingery
  
cancer cell divides
Cancer trial participation has remained at about 5% for decades. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D